Home LiteratureArticle Details
PMID: 2813378 Published · ppublish English Journal Article

Autocrine mechanism for v-sis transformation requires cell surface localization of internally activated growth factor receptors.

Fleming TP, Matsui T, Molloy CJ, Robbins KC, Aaronson SA

Abstract

v-sis represents a prototype for the class of oncogenes that encode growth factors. Whether its platelet-derived growth factor (PDGF)-like product functionally activates its receptors within the cell or at the cell surface has potential implications in efforts to intervene with the v-sis-transformed phenotype. We demonstrate that intracellular as well as cell surface forms of two PDGF receptor gene products are tyrosine phosphorylated in v-sis transformants. In a chemically defined medium in which cell growth was dependent on v-sis expression, proliferation was partially inhibited by PDGF neutralizing antibody but completely blocked by suramin. Suramin treatment resulted in a marked reduction in tyrosine phosphorylated cell surface PDGF receptors but had no effect on the level of tyrosine phosphorylation of intracellular receptor species. All of these findings demonstrate that the v-sis-encoded mitogen can bind and activate its receptors internally but that activated receptors must achieve a cell surface location in order to functionally couple with intracellular mitogenic signaling pathways.

MeSH Terms
Animals Cell Division/drug effects Cell Transformation, Neoplastic Cells, Cultured DNA Replication/drug effects Kinetics Mice Oncogene Proteins v-sis Oncogenes Platelet-Derived Growth Factor/pharmacology Retroviridae Proteins, Oncogenic/physiology Suramin/pharmacology Transforming Growth Factors/physiology
Chemicals
Oncogene Proteins v-sis Platelet-Derived Growth Factor Retroviridae Proteins, Oncogenic Suramin Transforming Growth Factors
Authors & Affiliations
5 authors, click to expand affiliations / ORCID
Fleming T P
Laboratory of Cellular and Molecular Biology, National Cancer Institute, Bethesda, MD 20892.
Matsui T
Molloy C J
Robbins K C
Aaronson S A
References (39)
39 references, click to expand
  1. Murine sarcoma and leukemia viruses: assay using clonal lines of contact-inhibited mouse cells.
    J Virol. 1969 Nov;4(5):549-53 PMID: 4311790
  2. Isolation of a novel receptor cDNA establishes the existence of two PDGF receptor genes.
    Science. 1989 Feb 10;243(4892):800-4 PMID: 2536956
  3. Simian sarcoma virus onc gene, v-sis, is derived from the gene (or genes) encoding a platelet-derived growth factor.
    Science. 1983 Jul 15;221(4607):275-7 PMID: 6304883
  4. Platelet-derived growth factor is structurally related to the putative transforming protein p28sis of simian sarcoma virus.
    Nature. 1983 Jul 7-13;304(5921):35-9 PMID: 6306471
  5. Close similarity of epidermal growth factor receptor and v-erb-B oncogene protein sequences.
    Nature. 1984 Feb 9-15;307(5951):521-7 PMID: 6320011
  6. Stimulation of 3T3 cells induces transcription of the c-fos proto-oncogene.
    Nature. 1984 Oct 4-10;311(5985):433-8 PMID: 6090941
  7. Transforming protein of simian sarcoma virus stimulates autocrine growth of SSV-transformed cells through PDGF cell-surface receptors.
    Cell. 1984 Nov;39(1):79-87 PMID: 6091918
  8. Inositol trisphosphate, a novel second messenger in cellular signal transduction.
    Nature. 1984 Nov 22-28;312(5992):315-21 PMID: 6095092
  9. Spontaneous production of fibroblast-activating factor(s) by synovial inflammatory cells. A potential mechanism for enhanced tissue destruction.
    J Exp Med. 1985 Jan 1;161(1):210-22 PMID: 3968518
  10. The c-fms proto-oncogene product is related to the receptor for the mononuclear phagocyte growth factor, CSF-1.
    Cell. 1985 Jul;41(3):665-76 PMID: 2408759
  11. The v-sis/PDGF-2 transforming gene product localizes to cell membranes but is not a secretory protein.
    EMBO J. 1985 Jul;4(7):1783-92 PMID: 2992941
  12. Bombesin-like peptides can function as autocrine growth factors in human small-cell lung cancer.
    Nature. 1985 Aug 29-Sep 4;316(6031):823-6 PMID: 2993906
  13. Antibodies against platelet-derived growth factor inhibit acute transformation by simian sarcoma virus.
    Nature. 1985 Oct 3-9;317(6036):438-40 PMID: 2995828
  14. Evidence that the v-sis gene product transforms by interaction with the receptor for platelet-derived growth factor.
    Science. 1985 Oct 18;230(4723):327-30 PMID: 2996133
  15. The product of the protooncogene c-src is modified during the cellular response to platelet-derived growth factor.
    Proc Natl Acad Sci U S A. 1985 Dec;82(23):7845-9 PMID: 2415973
  16. The pathogenesis of atherosclerosis--an update.
    N Engl J Med. 1986 Feb 20;314(8):488-500 PMID: 3511384
  17. Structural alteration of viral homologue of receptor proto-oncogene fms at carboxyl terminus.
    Nature. 1986 Mar 20-26;320(6059):277-80 PMID: 2421165
  18. Transformation by the v-fms oncogene product: role of glycosylational processing and cell surface expression.
    Mol Cell Biol. 1985 Dec;5(12):3467-75 PMID: 3018522
  19. Efficient reversion of simian sarcoma virus-transformation and inhibition of growth factor-induced mitogenesis by suramin.
    Proc Natl Acad Sci U S A. 1986 Sep;83(17):6440-4 PMID: 3018732
  20. Structure of the receptor for platelet-derived growth factor helps define a family of closely related growth factor receptors.
    Nature. 1986 Sep 18-24;323(6085):226-32 PMID: 3020426
  21. Synthesis of messenger RNAs for transforming growth factors alpha and beta and the epidermal growth factor receptor by human tumors.
    Cancer Res. 1987 Feb 1;47(3):707-12 PMID: 3467839
  22. Platelet-derived growth factor as a mediator of normal and neoplastic cell proliferation.
    Med Oncol Tumor Pharmacother. 1986;3(3-4):177-83 PMID: 3543531
  23. Progress in unraveling pathways of Golgi traffic.
    Annu Rev Cell Biol. 1985;1:447-88 PMID: 3916320
  24. The human transforming growth factor type alpha coding sequence is not a direct-acting oncogene when overexpressed in NIH 3T3 cells.
    Proc Natl Acad Sci U S A. 1987 Jun;84(11):3733-7 PMID: 3035551
  25. erbB-2 is a potent oncogene when overexpressed in NIH/3T3 cells.
    Science. 1987 Jul 10;237(4811):178-82 PMID: 2885917
  26. Overexpression of the human EGF receptor confers an EGF-dependent transformed phenotype to NIH 3T3 cells.
    Cell. 1987 Dec 24;51(6):1063-70 PMID: 3500791
  27. Growth factors with heparin binding affinity in human synovial fluid.
    Proc Soc Exp Biol Med. 1987 Dec;186(3):384-9 PMID: 3423022
  28. Human proto-oncogene c-kit: a new cell surface receptor tyrosine kinase for an unidentified ligand.
    EMBO J. 1987 Nov;6(11):3341-51 PMID: 2448137
  29. Autocrine stimulation of intracellular PDGF receptors in v-sis-transformed cells.
    Science. 1988 Feb 19;239(4842):914-6 PMID: 2829358
  30. Detection of PDGF-2 homodimers in human tumor cells.
    Oncogene. 1987 Mar;1(1):79-85 PMID: 3325876
  31. Overproduction of protein kinase C causes disordered growth control in rat fibroblasts.
    Cell. 1988 Feb 12;52(3):343-54 PMID: 3345563
  32. Altered growth regulation and enhanced tumorigenicity of NIH 3T3 fibroblasts transfected with protein kinase C-I cDNA.
    Cell. 1988 Feb 12;52(3):447-58 PMID: 3162207
  33. Two classes of PDGF receptor recognize different isoforms of PDGF.
    Science. 1988 Jun 10;240(4858):1529-31 PMID: 2836952
  34. Autocrine stimulation by the v-sis gene product requires a ligand-receptor interaction at the cell surface.
    J Cell Biol. 1988 Jul;107(1):287-98 PMID: 2455725
  35. Primary structure of c-kit: relationship with the CSF-1/PDGF receptor kinase family--oncogenic activation of v-kit involves deletion of extracellular domain and C terminus.
    EMBO J. 1988 Apr;7(4):1003-11 PMID: 2456920
  36. Binding of different dimeric forms of PDGF to human fibroblasts: evidence for two separate receptor types.
    EMBO J. 1988 May;7(5):1387-93 PMID: 2842148
  37. Rapid turnover of the platelet-derived growth factor receptor in sis-transformed cells and reversal by suramin. Implications for the mechanism of autocrine transformation.
    J Biol Chem. 1988 Sep 5;263(25):12608-18 PMID: 2842336
  38. Comparison of biological properties and transforming potential of human PDGF-A and PDGF-B chains.
    Science. 1988 Sep 9;241(4871):1346-9 PMID: 2842868
  39. Suramin: with special reference to onchocerciasis.
    Adv Pharmacol Chemother. 1978;15:289-322 PMID: 358805
Article Info
Journal
Proceedings of the National Academy of Sciences of the United States of America
Abbr.
Proc Natl Acad Sci U S A
ISSN
0027-8424
Published
1989-10-00
Pages
8063-7
Language
English
Region
United States
NLM ID
7505876
PMCID
PMC298215
Subset
IM
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com